1. Home
  2. IZM vs GOVX Comparison

IZM vs GOVX Comparison

Compare IZM & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICZOOM Group Inc.

IZM

ICZOOM Group Inc.

HOLD

Current Price

$0.84

Market Cap

2.3M

ML Signal

HOLD

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

BUY

Current Price

$0.25

Market Cap

3.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
IZM
GOVX
Founded
2011
2001
Country
China
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3M
3.0M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
IZM
GOVX
Price
$0.84
$0.25
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
★ 1.1M
799.2K
Earning Date
10-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $2,489,145.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.39
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.21
$0.24
52 Week High
$2.73
$152.50

Technical Indicators

Market Signals
Indicator
IZM
GOVX
Relative Strength Index (RSI) 47.44 21.38
Support Level $0.28 N/A
Resistance Level $0.94 $0.46
Average True Range (ATR) 0.14 0.04
MACD -0.05 0.00
Stochastic Oscillator 19.25 9.53

Price Performance

Historical Comparison
IZM
GOVX

About IZM ICZOOM Group Inc.

ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

Share on Social Networks: